Medcom Tech

Medcom Tech Quick Ratio

Delisted

The Quick Ratio (Acid Test) of Medcom Tech (MED.MC) as of Sep 17, 2026 is 0.74. In the previous year, Quick Ratio (Acid Test) was 0.68 — a change of 9.00% (higher).

Quick Ratio

0.74

YoY

9.00%

Last updated:

Quick Ratio (Acid Test) of Medcom Tech is 2026 0.74 . Quick Ratio (Acid Test) of Medcom Tech was 2025 0.68 . It decreases by 9.00% higher compared to the previous year.
Access this data via the Eulerpool API

Medcom Tech Stock analysis

What does Medcom Tech do? Medcom Tech SA is a European company headquartered in Switzerland that specializes in the development and manufacturing of medical devices. The company was founded in 1999 and has since had an impressive history. The business model of Medcom Tech SA is based on the idea of developing medical devices that meet the needs of doctors and patients. The company works closely with medical professionals to find innovative solutions that can improve medical care and accelerate patient recovery. The goal of Medcom Tech SA is to offer high-quality, safe, and reliable products that can be used worldwide in medical practice. Medcom Tech SA offers a wide range of products divided into various sectors. One of the main sectors of the company is gastroenterology, where endoscopic devices and accessories are manufactured and distributed. These devices are a crucial foundation for the diagnosis and treatment of gastrointestinal diseases. The endoscopes enable more precise interventions and are particularly in demand for minimally invasive procedures. Another important sector of the company is cardiology. Medcom Tech SA manufactures defibrillators and implantable devices in this sector. These devices help save lives and provide patients with more security in their daily lives. In particular, implantable devices are an essential part of modern medicine and contribute to allowing patients to lead long and healthy lives. In addition to the mentioned sectors, Medcom Tech also develops and produces devices for the diagnosis and treatment of respiratory diseases, neurology, gynecology, and urology. For example, in urology, a product called ProstateCare has been developed, which is an innovative method for treating benign prostatic hyperplasia (BPH), a benign enlargement of the prostate gland. Medcom Tech SA receives support in these business sectors from a network of international distribution partners who help distribute the products worldwide. In conclusion, Medcom Tech SA has undergone an impressive development and is one of the leading companies in the medical device industry. The company has earned an excellent reputation in the medical industry and is known for its innovative solutions and high-quality products. The continuous collaboration with medical professionals and the consistent development of new technologies and products make Medcom Tech an important partner in the medical care world. Medcom Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medcom Tech stock

Quick Ratio (Acid Test) of Medcom Tech is 0.74 in 2026.

Quick Ratio (Acid Test) of Medcom Tech changed from 0.68 to 0.74, representing a 9.00% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Medcom Tech since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Medcom Tech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Medcom Tech

All Key Metrics — Medcom Tech